Tawin is probably a smart bet for few months.

According to its Annoucement earlier. it stated in the prospectus that the Right issue matters are expect to be completed in the first quarter of 2021. That mean to say either in Jan, Feb or March.

Tawin trading volume reduce significantly whilst prices steadily hold and rise. i guess those "any force selling" and "short term players" are already flashed out. And current share price may be solid and stable. So awaiting some good news or "new catalyst" to boost it up.

Furthermore Tawin-PA is still "in the money". and can be convert to mother shares anytime from now up to August 2024.

Afraid of Right issue?? buy Tawin-PA you dont need to source funds for the right shares later.

Instead of posting the annoucement here again, i think i try to highlight some silent points/ interpretations in the proposed investment may be of intetest to some of us.
1. Royce join Tawin group as an associate company whereby it shall remain and maintance as a Bumiputra status company.
2. Tawin shall has two direstors in Royce board which comprises of another three from Jelita(holder of balance 67.5%)
3. Tawin has retained 5 millions of the investment cost as a security of the two years profit guarantee.
4. Government has allocated 31.9 billions for the Ministry of Health next year
5. Royce may explore the "Halal" sector of pharmaceutical business, even possibly to the Arab countries. Investors seeking a niche in the pharmaceutical industry with significant growth potential should consider the halal sector.
6. On Vaccine topic, Royce has pontential to become a distribution arm for the government or Royce may import other vaccine from China or Russia.
7. On copper issues. With Royce collaborations, the potential of developing the downstream usage of copper in the bio chemistry areas cannot be under estimated.
8. Royce is registered with the National Pharmaceutical Regulatory Agency (“NPRA”) and non pharmaceutical products under the Approved Product Purchase List (“APPL”) which was approved by the Government of Malaysia
to the hospitals, health office, health clinic, dental clinic, health institutions.
9. This proposal of investment is NOT requiring Tawin shareholders approval. Expected completion by end of 4th Quarter of 2020.

The above are not an exhautive list of the points, and is not a statement to solicit, promote, encourage or recommendation to buy any shares, non it is a representation from any company. I disclaim any liabilities whatsoever.

@Peace99. Thanks for the compliments.
Those are facts i extracted from the company annouced informations only.
I was wrong on the optimistic of the markets yesterday. The share price movement yesterday was really disappointing.
I though they have also signed a MOU or something approval on the Vaccine import. but it wasn't.
Anyway keep a close eye again.

Barring unforseen circumstances, Tawin shares prices limit up today.
It was trading well above 50 sens in the years 2017 and 2018 till first half year of 2019. when those years copper prices were well below current prices and Tawin has not rebranded and diversified as compare to now.
Tawin is now re strategised and rebranbed to diversified into property development and pharmaceutical industries. Under the dynamic steering leadership of Dato Ngu Tieng Ung, Tawin future is only better and brighter.

Talking on share prices. if we compare with the recent "vaccine play" counters namely Bintai, Solution, Mtronic, YongTai, Kanger, ..etc. Those companies were merely signed a MOU with foreign suppliers, they still need to obtain government approval for importing and distribution of vaccine. Whilst Tawin is directly buying a pharmaceutical company Royce. Thus chances of doing the vaccine business is higher.

Tawin can be taken as a good medium term share investment, in view of the possibility of involving in the upcoming Covid 19 vaccine businesses, which may close a deal soon via Royce.

20.85 millions to invest for 32.5%, plus profit guarantee of 10millions each for two years.
Tawin's share of 32.5% profit guarantee will be 6 millions in two years.
With good prospects outlook for Pharmaceutical industries and business.
This deal looks a wise and good investment.

https://www.klsescreener.com/v2/news/view/766079

Today signing ceremony was witnessed by the deputy human resource minister. Royce is looks like well connect or good rapport with the government.

Royce Pharma is registered with NPRA and as one of the few approved suppliers to the Government. I think we can expect Royce can get a fairly handsome shares of the Covid vaccine supplies to the government in the coming months.

Royce Pharma manufactures and supply pharmaceutical products (drugs and supplements)
registered with the National Pharmaceutical Regulatory Agency (“NPRA”) and non￾pharmaceutical products (medical disposables, equipment and devices) under the Approved
Product Purchase List (“APPL”) which was approved by the Government of Malaysia
(“Government”) to the hospitals, health office, health clinic, dental clinic, health institution or any
other similar facility within Malaysia which is operated and controlled by the Government
(“Government Healthcare Facilities”) through Skim Anak Angkat (“SAA”), Skim Panel Pembuat
Bumiputra (“SPPB”) and Medical and Laboratory Store Privatisation Concession Agreement.
As at the LPD, Royce Pharma has 65 drugs registered with the Drug Control Authority of the
Ministry of Health Malaysia and Royce Pharma is contracted to manufacture and supply 25 of
them to the Government Healthcare Facilities until 31 December 2021 under the supply
agreements dated 17 August 2017 and 26 March 2019 contracted with the Government and
extension letter dated 20 November 2019 received by Royce Pharma

RoycePharma President statement. He is a Tan Sri Son.

https://www.royce-pharma.com/presidents.php

I Googled the web and know that the chairman of RoycePharma is the son of a Tan Sri.

The share prices of few Vaccine counters listed below for references. (Low , high, now)

Bintai 0.15(Aug) 1.50(high) 1.68(now)
Solution 0.30(Aug) 2.00(high) 1.68(now)
HWGB 0.45(Jul) 1.50(high) 0.75(now)
YongTai 0.14(Nov) 046(high) 0.34(now)
Mtronic 0.05(Oct) 0.20(high) 0.12(Now)
HongSeng 0.18(Jul) 1.90(high) 1.03(now)
Kanger 0.10(Jul) 0.33(high) 0.165(now)

upcoming vaccine play counter is Tawin. Watch out.

Tawin is said to buy 30% equity shares of RoycePharma，a 15 years old pharmaceutical company and registered holder of MDA's establisment license approved to import and dustribution of medical devices and possibly the Covid vaccine. RoycePharma is likely to have connection of the China Shanghai Fosan Vaccine.
Upcoming "vaccine play" counter to bet in.

Tawin could be the upcoming "Vaccine play" counter to watch for. Cos Tawin is buying over 30% of RoycePharma to getting involve in Vaccine business. RoycePharma is a registered holder of MDA's establishment License approved to do the import and distribution of medical devices and vaccine.

Next Vaccine counter to rise may be Tawin. because Tawin is buying over 30% of Royce Pharma. Royce is a registeted holder of MDA establisment license allowed to import and distribution of medical devices and drug including vaccine.

13/12/2020 9:47 AM

Next Vaccine counter to rise may be Tawin. because Tawin is buying over 30% of Royce Pharma.

https://www.klsescreener.com/v2/announcements/view/3274899

This agreement was terminated.

Copper prices is rising

http://uk.investing.com/commodities/copper?utm_source=investing_app&utm_medium=share_link&utm_campaign=share_instrument

Collect and accumulate before 14/12.

https://www.klsescreener.com/v2/announcements/view/51302

Tawin PA has much lesser floating units because Directors holding more PA.

The latest issue share capital of RM118,790,975.41 of the Company is represented by a total of 446,075,920 ordinary shares and 350,063,380 Irredeemable Convertible Preference Shares ("ICPS").

Tawin-PA has good leverage, and "in the money"..
1 lot PA + 0.075 convertible to 1 Lot shares
0.12 + 0.075 = 0.195 (still below 0.225)
PA is a good buy.

The ICPS can be converted into new Shares at the conversion price of RM0.10 ("Conversion Price") in the following manner:

(a) 4 ICPS to be converted into 1 new Share; or

(b) a combination of such number of ICPS and cash with an aggregate value equal to the Conversion Price, subject to a minimum of 1 ICPS, and paying the difference between the aggregate value of the Issue Price of the ICPS surrendered and the Conversion Price in cash for 1 new Share.

The ICPS may be converted any time within 5 years commencing on and including the issue date of the ICPS up to and including the maturity date. Any remaining ICPS that are not converted by the maturity date shall be automatically converted into new Shares at the conversion ratio of 4 ICPS for 1 new Share.

https://www.bursamalaysia.com/market_information/announcements/company...

i dont know who is kukuman. but i know he is right this round. lets wait and see.

haha. believe kukuman no regret.

good time to collect more today. next monday may be a good day as kukuman indicated.

Morning sunrise. now is just 7.00AM.... haha

As i mentioned earlier. i hope a strong catylst may come any time soon. Grab the opportunities !!

Tawin PA is "in the money". worth buying.
One lot of PA plus cash 0.075 to convert into one mother share.
Buying PA is well leveraged and furthermore no obligation on the impending right issue.
My view is PA is better than WA.

Copper rose as much as 2.6% to $7,692.50 a ton, the highest since March 2013. The metal traded at $7,634 by 9:55 a.m. London time and is heading for the biggest monthly gain since 2016.

Copper commodities price now is at 7years highest.

https://uk.investing.com/news/commodities-news/copper-shines-gold-struggles-as-investors-chase-riskier-assets-2258984

Tawin has impending right issue. if you dont prepare to fund in or pay up more at the right shares alloted, buying PA now is the best way, yet also enjoying its up trending. And PA price now is still "in the money" if you chose to convert by paying 7.5 Sen per unit to get mother share. Futhermore, floating PA units are lesser than mother shares simply because Directors are holding more substantially in PA. So to conclude, PA is a good buy.

Copper price is at its peak now. last peak was in end of 2017 when Tawin share prices shot up to RM 1. So this round of Copper peak should pushes Tawin prices to what level? If you search and compare the 5 year chart for both Copper and Tawin, you may get a clear picture of Tawin price movement in the next few months.

potential 5G counter... just buy while still cheap

Book NTA without the potential Gold reserves is already 13 sen. i believe if its "revaluated NTA" could be much much higher... so guys, buying at 9 sen is a big bargain. Go in fast before you regret...

EAH commenced its Integrated Tax System project on Jan. so the quarterly results for Apr-Jun should be impressive, annoucement is expected before this month end. Buy buy buy. quickly grab the share prices below 5 sen. Sharks also accumulating now and ready to fly soon

Anyone know the recent Private placement holders can freely sell their shares or not? if so, they can get immediate gain, which might resist the uptrend.

This counter will always, always make shareholders happy whenever a bull market come... buy buy buy before it is too late...

join trooper paktua73. add me +60128801961

Certainly Gold is better than mask & glove.

Below is the annoucement by directors.

On behalf of the Board, UOB Kay Hian wishes to announce that the Board had on 7 August 2020 resolved to fix the issue price for the Private Placement at RM0.0435 per Placement Share.

The issue price of RM0.0435 per Placement Share represents a discount of approximately 9.94% to the 5-day VWAP of Bornoil Shares up to and including 6 August 2020, being the last traded day of Bornoil Shares immediately preceding the price-fixing date of RM0.0483 per Bornoil Share.